The shares of Intercept Pharmaceuticals Inc (NASDAQ:ICPT) are trading higher today due to the report that the company is exploring a potential sale.
The stock price of the biopharmaceutical company surged more than 27% to...
The stock price of Intercept Pharmaceuticals Inc (NASDAQ:ICPT) skyrocketed by more than 281% after the company reported that clinical trial of its liver drug, obeticholic acid (OCA) was stopped early by Data Safety Monitoring...